BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3411399)

  • 1. Dilated cardiomyopathy with neutropenia, short stature, and abnormal carnitine metabolism.
    Ino T; Sherwood WG; Cutz E; Benson LN; Rose V; Freedom RM
    J Pediatr; 1988 Sep; 113(3):511-4. PubMed ID: 3411399
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiomyopathy and abnormal carnitine metabolism.
    Christensen E
    J Pediatr; 1989 May; 114(5):903. PubMed ID: 2634979
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial L-carnitine deficiency in a family of dogs with dilated cardiomyopathy.
    Keene BW; Panciera DP; Atkins CE; Regitz V; Schmidt MJ; Shug AL
    J Am Vet Med Assoc; 1991 Feb; 198(4):647-50. PubMed ID: 2019534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-carnitine supplementation in the therapy of canine dilated cardiomyopathy.
    Keene BW
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):1005-9. PubMed ID: 1949496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart failure in dilated cardiomyopathy and coronary heart disease. The contribution of biochemical parameters to assessing the prognosis].
    Regitz V; Shug AL; Schüler S; Yankah C; Hetzer R; Fleck E
    Dtsch Med Wochenschr; 1988 May; 113(19):781-6. PubMed ID: 3284737
    [No Abstract]   [Full Text] [Related]  

  • 6. Dilated cardiomyopathy caused by plasma membrane carnitine transport defect.
    Marques JS
    J Inherit Metab Dis; 1998 Jun; 21(4):428-9. PubMed ID: 9700603
    [No Abstract]   [Full Text] [Related]  

  • 7. Case report: efficacy of oral carnitine therapy for dilated cardiomyopathy in boxer dogs.
    Costa ND; Labuc RH
    J Nutr; 1994 Dec; 124(12 Suppl):2687S-2692S. PubMed ID: 7996270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children.
    Pierpont ME; Breningstall GN; Stanley CA; Singh A
    Am Heart J; 2000 Feb; 139(2 Pt 3):S96-S106. PubMed ID: 10650322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutropenia and glycogenosis type IB].
    Couselo Sánchez JM; López Rivas M; Pérez Becerra E; Rodríguez Cervilla J; Pavón Belinchón P; Fraga Bermúdez JM; Peña Guitián J
    An Esp Pediatr; 1983 Jun; 18(6):505-9. PubMed ID: 6578695
    [No Abstract]   [Full Text] [Related]  

  • 10. Dilated Cardiomyopathy as the Only Clinical Manifestation of Carnitine Transporter Deficiency.
    Papadopoulou-Legbelou K; Gogou M; Dokousli V; Eboriadou M; Evangeliou A
    Indian J Pediatr; 2017 Mar; 84(3):231-233. PubMed ID: 27807682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-up.
    Agnetti A; Bitton L; Tchana B; Raymond A; Carano N
    Int J Cardiol; 2013 Jan; 162(2):e34-5. PubMed ID: 22658351
    [No Abstract]   [Full Text] [Related]  

  • 12. [A cause of dilated cardiomyopathy in a child: primary carnitine deficiency].
    Baragou S; Pio M; Di Bernardo S; Ksontini TB; Dommange SJ; Bonafe L; Meijboom E; Sekarski N
    Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):107-10. PubMed ID: 22260907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases.
    Regitz V; Shug AL; Fleck E
    Am J Cardiol; 1990 Mar; 65(11):755-60. PubMed ID: 2316456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration.
    Rizos I
    Am Heart J; 2000 Feb; 139(2 Pt 3):S120-3. PubMed ID: 10650325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dilated cardiomyopathy due to primary carnitine deficiency].
    Squarcia U; Agnetti A; Caffarra A; Cavalli C; Marbini A
    Pediatr Med Chir; 1986; 8(2):157-61. PubMed ID: 3786176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of L-carnitine on nutritional status in juvenile idiopathic dilated cardiomyopathy].
    Azeka E
    J Pediatr (Rio J); 2005; 81(5):355-6. PubMed ID: 16247533
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter.
    Bennett MJ; Hale DE; Pollitt RJ; Stanley CA; Variend S
    Clin Cardiol; 1996 Mar; 19(3):243-6. PubMed ID: 8674264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital pancreatic hypoplasia with neutropenia and skeletal abnormalities.
    McCollum JP; Muller DP; Harries JT
    Proc R Soc Med; 1975 May; 68(5):304-5. PubMed ID: 1082594
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening.
    Lee NC; Tang NL; Chien YH; Chen CA; Lin SJ; Chiu PC; Huang AC; Hwu WL
    Mol Genet Metab; 2010 May; 100(1):46-50. PubMed ID: 20074989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barth syndrome: clinical observations and genetic linkage studies.
    Christodoulou J; McInnes RR; Jay V; Wilson G; Becker LE; Lehotay DC; Platt BA; Bridge PJ; Robinson BH; Clarke JT
    Am J Med Genet; 1994 Apr; 50(3):255-64. PubMed ID: 8042670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.